Study on the Efficacy and Safety of QLM1016 in Schizophrenia
Clinical trial NCT06799559 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06799559
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-01
- Primary completion
- 2026-07-01
- Enrollment
- 402
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.